title: Comment on: The use of erythromycin as a gastrointestinal prokinetic agent in adult critical care: benefits versus risks.
authors.forename: Adam
authors.initials: A
authors.lastname: Deane
authors.forename: Robert
authors.initials: R
authors.lastname: Young
mesh_terms: D000328:Adult; D003422:Critical Care / Q000379:methods*; D024881:Drug Resistance, Bacterial; D004917:Erythromycin / Q000008:administration & dosage / Q000627:therapeutic use*; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D005769:Gastrointestinal Motility / Q000187:drug effects*; D006801:Humans
chemical_list: D005765:Gastrointestinal Agents; D004917:Erythromycin